Related Experiment Video

Updated: Jul 5, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting

Yongsheng Lan1, Yongyou Zhang, Jianghua Wang

  • 1Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030-3303, USA.

International Journal of Cancer
|May 24, 2008
PubMed

Insights

Elevated Cks1 and Cks2 proteins drive prostate cancer growth and survival. Inhibiting these proteins may offer a new therapeutic strategy for treating prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Cks protein family, comprising Cks1 and Cks2, plays roles in cell cycle regulation.
  • Elevated Cks1 and Cks2 expression is linked to various cancers and poorer patient survival.
  • The specific roles of Cks1 and Cks2 in prostate cancer development are not fully elucidated.

Purpose of the Study:

  • To investigate the role of Cks1 and Cks2 in prostate tumorigenesis.
  • To determine the impact of Cks1 and Cks2 expression on prostate cancer cell behavior.
  • To explore the potential of targeting Cks1 and Cks2 as a therapeutic strategy for prostate cancer.

Main Methods:

  • Analysis of Cks1 and Cks2 expression in human and animal prostate tumor models and cell lines.
  • Forced expression of Cks1 and Cks2 in benign prostate epithelial cells.
  • Knockdown of Cks1 and Cks2 expression in malignant prostate cancer cells.

Main Results:

  • Cks1 and Cks2 expression were found to be elevated in prostate tumors and cell lines.
  • Forced expression of Cks1 and Cks2 promoted cell proliferation in benign prostate cells.
  • Cks1 knockdown inhibited proliferation, growth, and migration in malignant prostate cells.
  • Cks2 knockdown induced apoptosis and reduced tumorigenicity in malignant prostate cells.

Conclusions:

  • Elevated Cks1 promotes prostate tumor cell growth and tumorigenicity.
  • Elevated Cks2 protects prostate cancer cells from apoptosis, enhancing survival.
  • Targeting Cks1 and Cks2 presents a potential novel therapeutic approach for prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...